Methylene blue attenuates lung injury after mesenteric artery clamping/unclamping

European Journal of Clinical Investigation

Volumn 34, Issue 6, 2004, Pages 436-442

  Weinbroum, A A ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Injury; Intestine; Ischaemia reperfusion; Lung; Methylene blue; Trachea

Indexed keywords

METHYLENE BLUE; XANTHINE OXIDASE;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; LEUKOCYTE COUNT; LUNG ALVEOLUS CELL; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; NEUTROPHIL; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SUPERIOR MESENTERIC ARTERY; SURVIVAL TIME; WEIGHT;

ADMINISTRATION, ORAL; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CONSTRICTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; LUNG; MALE; MESENTERIC ARTERY, SUPERIOR; METHYLENE BLUE; RATS; REPERFUSION INJURY; RESPIRATION;

EID: 3042718941     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01361.x     Document Type: Article

References (33)

1. Lee F. Oxidants injury to pulmonary endothelium. In: Said SI, editor. The Pulmonary Circulation and Acute Lung Injury, 2nd edn. Mount Kisco NY, Futura Publishing Co. Inc., 1991:pp.403-32.
2. Lu YT, Hellewell PG, Evans TW. Ischemia-reperfusion lung injury: contribution of ischemia, neutrophils, and hydrostatic pressure. Am J Physiol 1997;273:L46-L54.
3. Weinbroum AA, Goldman G, Kluger Y, Hag M, Marmor S, Sorkine P et al. Bowel ischemia/reperfusion-induced liver and lung injury: elemental role of eicosanoids and oxygen free radicals. Med Sci Monit 1997;3:624-30.
4. Weinbroum AA, Hochhauser E, Rudick V, Kluger Y, Karchevsky E, Vidne BA. Mediation of multiple organ dysfunction by radical oxygen species following remote circulatory arrest. Common mechanism of action? J Trauma 1999;47:691-8.
5. Kelner MJ, Bagnell R, Hale B, Alexander NM. Potential of methylene blue to block oxygen radical generation in reperfusion injury. Basic Life Sci 1988;49:895-8.
6. Weinbroum AA, Kluger Y, Shapira I, Rudick V. Methylene blue abolishes aortal tone impairment induced by liver ischemia-reperfusion in a dose-response manner: an isolated-perfused double-organ rat model study. Shock 2001;15:226-30.
7. Galili Y, Ben-Abraham R, Weinbroum A, Marmur S, Iaina A, Volman Y et al. Methylene blue prevents pulmonary injury following intestinal ischemia reperfusion. J Trauma 1998;45:222-6.
8. Weinbroum AA, Goldin I, Kluger Y, Szold A. Methylene blue in preventing hemodynamic and metabolic derangement following superior mesenteric artery clamping/unclamping: an intratracheal vs. intraperitoneal dose-response study. Shock 2002;17:372-6.
9. Barnard ML, Baker RR, Matalon S. Mitigation of oxidant injury to lung microvasculature by intratracheal instillation of antioxidant enzymes. Am J Physiol 1993;265:L340-5.
10. Effros RM, Murphy C, Hacker A, Schapira RM, Bongard R. Reduction and uptake of methylene blue from rat air spaces. J Appl Physiol 1994;77:1460-5.
11. Orlowski JP. Emergency alternatives to intravenous access. Intraosseous, intratracheal, sublingual, and other-site drug administration. Pediatr Clin North Am 1994;41:1183-99.
12. Kirov MY, Evgenov OV, Bjertnaes LJ. Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep. Crit Care Med 2003;31:179-86.
13. Evgenov OV, Sager G, Bjertnaes LJ. Methylene blue reduces lung fluid filtration during the early phase of endotoxemia in awake sheep. Crit Care Med 2001;29:374-9.
14. Zhang H, Rogiers P, Preiser JC, Spapen H, Manikis P, Metz G et al. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med 1995;23:1711-21.
15. Weinbroum AA, Paret G, Szold O, Rudick V, Krupitzky L. Selective attenuation of acute lung ventilatory injury by methylene blue after liver ischemia-reperfusion: a drug response study in an isolated perfused double organ model. Transplantation 2001;72:385-92.
16. Hashimoto S. A new spectrophotometric assay method of xanthine oxidase in crude tissue homogenate. Anal Biochem 1974;62:426-35.
17. Andresen M, Dougnac A, Diaz O, Hernandez G, Castillo L, Bugedo G et al. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange. J Crit Care 1998;13:164-8.
18. Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care 2002;30:755-62.
19. Grayling M, Deakin CD. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis. J Thorac Cardiovasc Surg 2003;125:426-7.
20. Kirov MY, Evgenov OV, Evgenov NV, Egorina EM, Sovershaev MA, Sveinbjornsson B et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med 2001;29:1860-7.
21. Weinbroum A, Nielsen VG, Tan S, Gelman S, Matalon S, Bradley E Jr et al. Liver ischemia-reperfusion increases pulmonary permeability in the rat: role of circulating xanthine oxidase. Am J Physiol 1995;268:G988-96.
22. Terada LS, Dormish JJ, Shanley PF, Leff JA, Anderson BO, Repine JE. Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. Am J Physiol 1992;263:L394-L401.
23. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
24. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993;45:367-74.
25. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther 1986;237:893-900.
26. Kim JJ, Moon DG, Koh SK. The role of nitric oxide in vivo feline erection under hypoxia. Int J Impot Res 1998;10:145-51.
27. Cobb JP, Natanson C, Hoffman WD, Lodato RF, Banks S, Koev CA et al. N-omega-amino-L-arginine, an inhibitor of nitric oxide synthase raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992;176:1175-82.
28. Koike K, Moore EE, Moore FA, Kim FJ, Carl VS, Banerjee A. Gut phospholipase A2 mediates neutrophil priming and lung injury after mesenteric ischemia-reperfusion. Am J Physiol 1995;268:G397-G403.
29. Hansbrough JF, Wikstrom T, Braide M, Tenenhaus M, Rennekampff OH, Kiessig V et al. Neutrophil activation and tissue neutrophil sequestration in a rat model of thermal injury. J Surg Res 1996;61:17-22.
30. Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 1995;82:1026-60.
31. Kretzschmar M, Klein U, Palutke M, Schirrmeister W. Reduction of ischemia-reperfusion syndrome after abdominal aortic aneurysmectomy by N-acetylcysteine but not mannitol. Acta Anaesthesiol Scand 1996;40:657-64.
32. Emre S, Schwartz ME, Katz E, Miller CM. Liver resection under total vascular isolation. Variations on a theme. Ann Surg 1993;217:15-9.
33. Larsen M, Webb G, Kennington S, Kelleher N, Sheppard J, Kuo J et al. Mannitol in cardioplegia as an oxygen free radical scavenger measured by malondialdehyde. Perfusion 2002;17:51-5.